189 related articles for article (PubMed ID: 35734550)
1. Tacrolimus Combined with Corticosteroids Improved the Outcome of CIDP Patients with Autoantibodies Against Paranodal Proteins.
Yang MG; Xu L; Ji S; Gao H; Zhang Q; Bu B
Neuropsychiatr Dis Treat; 2022; 18():1207-1217. PubMed ID: 35734550
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the patients with antibodies against nodal-paranodal junction proteins in chronic inflammatory demyelinating polyneuropathy.
Dong M; Tai H; Yang S; Gao X; Pan H; Zhang Z
Clin Neurol Neurosurg; 2022 Dec; 223():107521. PubMed ID: 36401951
[TBL] [Abstract][Full Text] [Related]
3. Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey.
Hashimoto Y; Ogata H; Yamasaki R; Sasaguri T; Ko S; Yamashita K; Xu Z; Matsushita T; Tateishi T; Akiyama S; Maruyama S; Yamamoto A; Kira JI
Front Neurol; 2018; 9():997. PubMed ID: 30538665
[No Abstract] [Full Text] [Related]
4. Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy.
Pascual-Goñi E; Fehmi J; Lleixà C; Martín-Aguilar L; Devaux J; Höftberger R; Delmont E; Doppler K; Sommer C; Radunovic A; Carvajal A; Smyth S; Williams L; Mazanec R; Potočková V; Hinds N; Cassereau J; Viala K; Lefilliatre M; Nicolas G; Foley P; Leypoldt F; Keddie S; Lunn MP; Zimprich F; Nunkoo VS; Löscher WN; Martínez-Martínez L; Díaz-Manera J; Rojas-Garcia R; Illa I; Rinaldi S; Querol L
Brain; 2021 May; 144(4):1183-1196. PubMed ID: 33880507
[TBL] [Abstract][Full Text] [Related]
5. Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Querol L; Rojas-García R; Diaz-Manera J; Barcena J; Pardo J; Ortega-Moreno A; Sedano MJ; Seró-Ballesteros L; Carvajal A; Ortiz N; Gallardo E; Illa I
Neurol Neuroimmunol Neuroinflamm; 2015 Oct; 2(5):e149. PubMed ID: 26401517
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.
Cortese A; Lombardi R; Briani C; Callegari I; Benedetti L; Manganelli F; Luigetti M; Ferrari S; Clerici AM; Marfia GA; Rigamonti A; Carpo M; Fazio R; Corbo M; Mazzeo A; Giannini F; Cosentino G; Zardini E; Currò R; Gastaldi M; Vegezzi E; Alfonsi E; Berardinelli A; Kouton L; Manso C; Giannotta C; Doneddu P; Dacci P; Piccolo L; Ruiz M; Salvalaggio A; De Michelis C; Spina E; Topa A; Bisogni G; Romano A; Mariotto S; Mataluni G; Cerri F; Stancanelli C; Sabatelli M; Schenone A; Marchioni E; Lauria G; Nobile-Orazio E; Devaux J; Franciotta D
Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31753915
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review and Meta-Analysis of Autoantibodies for Diagnosis and Prognosis in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Guo X; Tang L; Huang Q; Tang X
Front Neurosci; 2021; 15():637336. PubMed ID: 34108854
[No Abstract] [Full Text] [Related]
8. Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy.
Tan CY; Goh KJ; Oh AW; Devaux J; Shahrizaila N
Neuromuscul Disord; 2022 Mar; 32(3):255-262. PubMed ID: 35183410
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Anti-Contactin1 Antibody-Associated Autoimmune Nodopathies With Concomitant Membranous Nephropathy.
Xu Q; Liu S; Zhang P; Wang Z; Chang X; Liu Y; Yan J; He R; Luo X; Zou LY; Chu X; Guo Y; Huang S; Fu X; Huang Y
Front Immunol; 2021; 12():759187. PubMed ID: 34675937
[TBL] [Abstract][Full Text] [Related]
10. Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy.
Zhang L; Zhang Y; Li R; Zhu J; Lin A; Yan Y; Zhang Z; Wang N; Xu G; Fu Y
J Neurol; 2024 May; ():. PubMed ID: 38771386
[TBL] [Abstract][Full Text] [Related]
11. Effect of monovalency on anti-contactin-1 IgG4.
Taieb G; Jentzer A; Vegezzi E; Lleixà C; Illa I; Querol L; Devaux JJ
Front Immunol; 2023; 14():1021513. PubMed ID: 36999029
[TBL] [Abstract][Full Text] [Related]
12. Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.
Kira JI
Front Neurol; 2021; 12():665136. PubMed ID: 34177770
[TBL] [Abstract][Full Text] [Related]
13. Nodal-paranodal antibodies in HIV-immune mediated radiculo-neuropathies: Clinical phenotypes and relevance.
Moodley K; Patel VB; Moodley AA; Bill PLA; Kajee A; Mgbachi V; Fehmi J; Rinaldi S
J Peripher Nerv Syst; 2023 Dec; 28(4):578-585. PubMed ID: 37676746
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera.
Delmont E; Brodovitch A; Kouton L; Allou T; Beltran S; Brisset M; Camdessanché JP; Cauquil C; Cirion J; Dubard T; Echaniz-Laguna A; Grapperon AM; Jauffret J; Juntas-Morales R; Kremer LD; Kuntzer T; Labeyrie C; Lanfranco L; Maisonobe T; Mavroudakis N; Mecharles-Darrigol S; Nicolas G; Noury JB; Perie M; Rajabally YA; Remiche G; Rouaud V; Tard C; Salort-Campana E; Verschueren A; Viala K; Wang A; Attarian S; Boucraut J
J Neurol; 2020 Dec; 267(12):3664-3672. PubMed ID: 32676765
[TBL] [Abstract][Full Text] [Related]
15. Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database.
Liberatore G; De Lorenzo A; Giannotta C; Manganelli F; Filosto M; Cosentino G; Cocito D; Briani C; Cortese A; Fazio R; Lauria G; Clerici AM; Rosso T; Marfia GA; Antonini G; Cavaletti G; Carpo M; Doneddu PE; Spina E; Cotti Piccinelli S; Peci E; Querol L; Nobile-Orazio E
Neurol Sci; 2022 Jun; 43(6):3939-3947. PubMed ID: 35048233
[TBL] [Abstract][Full Text] [Related]
16. Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.
Tang L; Huang Q; Qin Z; Tang X
J Neurol; 2021 Aug; 268(8):2757-2768. PubMed ID: 32266541
[TBL] [Abstract][Full Text] [Related]
17. Anti-neurofascin autoantibody and demyelination.
Kira JI; Yamasaki R; Ogata H
Neurochem Int; 2019 Nov; 130():104360. PubMed ID: 30582947
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Martinez-Hernandez E; Diaz-Manera J; Suárez-Calvet X; Navas M; Araque J; Gallardo E; Illa I
Ann Neurol; 2013 Mar; 73(3):370-80. PubMed ID: 23280477
[TBL] [Abstract][Full Text] [Related]
19. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
Koike H; Kadoya M; Kaida KI; Ikeda S; Kawagashira Y; Iijima M; Kato D; Ogata H; Yamasaki R; Matsukawa N; Kira JI; Katsuno M; Sobue G
J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies in chronic inflammatory demyelinating polyradiculoneuropathy.
Pascual-Goñi E; Martín-Aguilar L; Querol L
Curr Opin Neurol; 2019 Oct; 32(5):651-657. PubMed ID: 31306213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
